• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYBoard
  • MYInsights
  • Strategy & Consulting
  • Contact Us
Select Page

Exercise Improves Physical Abilities in Patients With Multiple Myeloma

by | Oct 3, 2023 | Uncategorized

Source: CureToday articles Patients with multiple myeloma who are undergoing systemic treatment can see improvements from exercise, a recent study shows. Read More

Immunoglobulin prevents infections associated with anti-BCMA therapy for multiple myeloma

by | Oct 2, 2023 | Uncategorized

Prophylactic IV immunoglobulin supplementation reduced the risk for severe infections by 90% among adults receiving a B-cell maturation antigen-directed bispecific antibody for treatment of multiple myeloma, study results showed.The findings — published in Blood...

Patients With Newly Diagnosed, High-Risk Myeloma See High MRD Negative Rates With Isa-KRd

by | Oct 1, 2023 | Uncategorized

Source: CureToday articles Treatment with the combination of Sarclisa, Kyprolis, Revlimid and Isa-KRd generated high rates of minimal residual disease negativity in patients with newly diagnosed, high-risk multiple myeloma, irrespective of transplant status. Read...

Mezigdomide Regimen Promising for Relapsed/Refractory Myeloma

by | Sep 29, 2023 | Uncategorized

Source: CureToday articles Mezigdomide plus Velcade and dexamethasone or Kyprolis and dexamethasone showed promising response rates across multiple doses in patients with relapsed or refractory multiple myeloma, research showed. Read More

Health care professionals express support for postpartum depression, myeloma treatments

by | Sep 28, 2023 | Uncategorized

Analysis of online conversations among health care professionals on social media during August revealed significant support for the first oral treatment for postpartum depression.The agency approved zuranolone (Zurzuvae, Sage Therapeutics) on Aug. 7.The analysis also...

Aphexda Plus Filgrastim Boosts Stem Cell Mobilization in Patients With Myeloma

by | Sep 27, 2023 | Uncategorized

Source: CureToday articles The recent FDA approval of Aphexda combined with filgrastim improved the collection of stem cells in patients with multiple myeloma. Read More
« Older Entries
Next Entries »

Recent Content

  • FDA OKs Investigational New Drug Application for VS-7375 in Solid Tumors
  • Hydroxyurea Produces Long-Term Clinical Benefits in Pediatrics With Sickle Cell Anemia
  • Crafting an Individual Treatment Plan for Patients With Prostate Cancer
  • DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer Chemotherapy
  • NCCN Flash Update: Changes to Colon Cancer Guidelines, Version 3.2025
  • Commitment to Patients Is Driven by a Lasting Promise
  • AAN 2025: Low-Sodium Oxybate Improves Sleep Quality, Daily Functioning in Narcolepsy, Idiopathic Hypersomnia
  • Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care
  • New Options for ER+ Breast Cancer Spotlighted at Patient Event
  • Asembia’s AXS25 Summit: Must-See Sessions, Expert Interviews as Specialty Pharmacy Gathers
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT